| PERIOD ENDING | 31-Oct-08 | 29-Feb-08 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
|
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 723 | 38 | | Non Recurring |
-
|
-
| | Others | 145 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (868) | (38) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,597 |
-
| | Earnings Before Interest And Taxes | 3,729 | (38) | | Interest Expense | 7,095 |
-
| | Income Before Tax | (3,366) | (38) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (3,366) | (38) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (3,366) | (38) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($3,366) | ($38) |
|
0.68% Nasdaq 
Income Statement
